Previous close | 7.40 |
Open | 7.40 |
Bid | 2.00 |
Ask | 11.00 |
Strike | 230.00 |
Expiry date | 2026-12-18 |
Day's range | 7.40 - 7.40 |
Contract range | N/A |
Volume | |
Open interest | 6 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning